Why the CSL (ASX:CSL) share price is up 5% in a week

What's next for CSL and plasma collections?

| More on:
woman in lab coat conducting testing representing biotech

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price has rallied strongly in the second half of this month, up 7.40% since 15 July to $295.55.

Broad buying across ASX 200 healthcare shares

The CSL share price isn't alone in its recent resurgence.

The S&P/ASX Health Care (INDEXASX: XHJ) index has also rallied 6% since 15 July.

The broad buying across the healthcare space has witnessed ASX 200 healthcare heavyweights Sonic Healthcare Limited (ASX: SHL) and ResMed Inc. (ASX: RMD) surge to new record highs.

Encouragingly, Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) and Cochlear Limited (ASX: COH) have also moved up strongly since mid-July, up 8.65% and 3.7% respectively.

What's next for the CSL share price?

The CSL share price could be a winner once the delta variant of COVID-19 subsides according to Peter Switzer.

His outlook was previously covered by The Motley Fool, highlighting why CSL could be a good long-term opportunity.

According to Switzer, "The company's biggest profit-maker is collecting plasma in the US, and the virus concerns scared off a lot of its donors who get paid to give blood. As normalcy comes back, demand for blood will rise, and that will be good for CSL's bottom line."

The CSL share price is still flat this year

The CSL share price is up about 3.5% year-to-date, underperforming the broader S&P/ASX 200 Index (ASX: XJO).

CSL's underwhelming performance is consistent with its international biotech peers such as Grifols.

Grifols is a Spanish multinational biotech company with a focus on producing blood plasma-based products.

Its shares have tumbled 13.66% year-to-date, but its quarterly results on 4 May reveal some positive commentary regarding plasma collections.

In the United States, plasma donations are gradually recovering. Of note was the trend observed in January, February and April in the wake of the country's vaccination rollouts and the easing of COVID-19 restrictions, while taking into account the mitigating effect of stimulus incentives issued in March and December.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »